Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Rating of “Moderate Buy” from Analysts

Billiontoone, Inc. (NASDAQ:BLLN) has received a consensus recommendation of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $126.7143.

A number of equities analysts have weighed in on the stock. Wall Street Zen downgraded shares of Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. JPMorgan Chase & Co. cut their target price on Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research report on Thursday, August 6th. BTIG Research lowered their price target on Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, August 6th. Guggenheim assumed coverage on Billiontoone in a research note on Monday, June 29th. They set a “buy” rating and a $125.00 price target for the company. Finally, Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 23rd.

Billiontoone Stock Up 1.8%

BLLN opened at $92.32 on Wednesday. Billiontoone has a 12 month low of $61.96 and a 12 month high of $150.44. The business has a 50-day moving average of $114.66 and a two-hundred day moving average of $95.33. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. The stock has a market capitalization of $4.36 billion and a price-to-earnings ratio of 131.89.

Billiontoone (NASDAQ:BLLN) last released its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The business had revenue of $109.45 million for the quarter. On average, research analysts expect that Billiontoone will post 0.83 earnings per share for the current year.

Insider Activity

In related news, insider Nancy Joann Johnson sold 10,582 shares of the company’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $100.47, for a total transaction of $1,063,173.54. Following the completion of the sale, the insider directly owned 21,900 shares of the company’s stock, valued at approximately $2,200,293. This represents a 32.58% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the firm’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $136.95, for a total value of $4,450,875.00. Following the completion of the transaction, the chief executive officer directly owned 20,000 shares in the company, valued at $2,739,000. This trade represents a 61.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 224,883 shares of company stock valued at $25,698,744. Company insiders own 50.22% of the company’s stock.

Institutional Trading of Billiontoone

Several large investors have recently bought and sold shares of BLLN. Rossby Financial LCC acquired a new position in shares of Billiontoone during the fourth quarter worth $25,000. Wells Fargo & Company MN acquired a new stake in Billiontoone during the 4th quarter valued at $76,000. Smartleaf Asset Management LLC purchased a new stake in Billiontoone during the 4th quarter worth $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in Billiontoone in the 4th quarter worth $82,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Billiontoone in the 4th quarter valued at about $230,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.